Inhibition of Increased Circulating TFH Cell by Anti-Cd20 Monoclonal Antibody in Patients With Type 1 Diabetes

PLoS ONE - United States
doi 10.1371/journal.pone.0079858
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Phase I Study of Chimeric Anti-Cd20 Monoclonal Antibody in Chinese Patients With CD20-positive Non-Hodgkin’s Lymphoma

Chinese Journal of Cancer Research
Cancer ResearchOncology
2016English

Immunomodulatory Activity of Humanized Anti–IL-7r Monoclonal Antibody RN168 in Subjects With Type 1 Diabetes

JCI insight
Medicine
2019English

Safety and Efficacy of Ofatumumab, a Fully Human Monoclonal Anti-Cd20 Antibody, in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: A Phase 1-2 Study

Blood
BiochemistryImmunologyCell BiologyHematology
2008English

Prevention of Type 1 Diabetes in the Rat With an Allele-Specific Anti–T-Cell Receptor Antibody

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes

Frontiers in Immunology
AllergyImmunology
2019English

A Phase 1 Study of Anti-TGFβ Receptor Type-Ii Monoclonal Antibody LY3022859 in Patients With Advanced Solid Tumors

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2017English

Circulating Endothelial Cells Are Elevated in Patients With Type 1 Diabetes Mellitus

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2010English

Circulating CXCR5+CXCR3+PD-1lo TFH-Like Cells in HIV-1 Controllers With Neutralizing Antibody Breadth

JCI insight
Medicine
2017English

Decreased Expression of Circulating Aire and Increased TFH/TFR Cells in Myasthenia Gravis Patients

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy